PTPN2 and colitis: To investigate whether prolonged inflammation and thus the involvement of the adaptive immune system would reveal an effect of PTPN2-deficient DCs on disease outcome, PTPN2fl/flxCD11cCre mice were subjected to chronic DSS-induced colitis by administration of 1.5% DSS for four cycles, followed by a final recovery phase of 4 weeks.